Resumé:           dr. Annelies Schulte

Dr. Schulte obtained a degree in biotechnology and plant physiology at Groningen University. During this time she discovered the use of plant cell cultures as flexible system to study plant biochemical and physiological processes.

At Leiden University, she continued for her PhD on plant cell cultures of Catharanthus roseus as a means to unravel the biosynthesis pathway to the valuable anti-cancer products vinblastine and vincristine.

During a post-doc position at TU-Delft, she worked on developing a method for random saturated mutagenesis to optimize industrial proteins.

In 1999, she joined the breeding company De Ruiter Seeds as R&D group leader of the Biotechnology and Seed Technology teams.

In 2005, she returned to Leiden University on her own grant to develop new, non-GMO, oligonucleotide-based technologies for optimization of plant (cell) production capacity and characteristics.

In 2009, she founded her Holding and ExPlant Technologies to further build on the use of plant cell and organ cultures as production platform for plant-based products and to continue development of oligonucleotide-based applications in plants. In addition service activities were developed to stimulate contract research options.

Alongside, she is active as Board Member of the Dutch Society for Medicinal Plant Research (NVGO) and co-organizer of the yearly NVGO Symposium.